Moisand Fitzgerald Tamayo’s United Therapeutics UTHR Stock Holding History

Moisand Fitzgerald Tamayo’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.88K	Hold	9	–	–	﹤0.01%	438
2026 Q1	$5.34K	Hold	9	–	–	﹤0.01%	400
2025 Q4	$4.39K	Hold	9	–	–	﹤0.01%	418
2025 Q3	$3.77K	Hold	9	–	–	﹤0.01%	459
2025 Q2	$2.59K	Hold	9	–	–	﹤0.01%	484
2025 Q1	$2.77K	Hold	9	–	–	﹤0.01%	471
2024 Q4	$3.18K	Hold	9	–	–	﹤0.01%	469
2024 Q3	$3.23K	Hold	9	–	–	﹤0.01%	481
2024 Q2	$2.87K	Hold	9	–	–	﹤0.01%	459
2024 Q1	$2.07K	Hold	9	–	–	﹤0.01%	488
2023 Q4	$1.98K	Hold	9	–	–	﹤0.01%	541
2023 Q3	$2.03K	Hold	9	–	–	﹤0.01%	556
2023 Q2	$1.99K	Hold	9	–	–	﹤0.01%	548
2023 Q1	$2.02K	Hold	9	–	–	﹤0.01%	557
2022 Q4	$2.5K	Buy	+9	New	+$2.27K	﹤0.01%	511

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Norges Bank Oslo, Norway $1T AUM

Moisand Fitzgerald Tamayo's UTHR Position: Q2 2026 in Review

Moisand Fitzgerald Tamayo held its United Therapeutics (UTHR) position steady in Q2 2026 at 9 shares worth $4.88K. The position accounts for ﹤0.01% of the portfolio, ranked #438.

Moisand Fitzgerald Tamayo first reported a position in UTHR in Q4 2022 and has held it in 15 quarters since. The position peaked at $5.34K in Q1 2026. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

Moisand Fitzgerald Tamayo held 9 shares of United Therapeutics worth $4.88K as of Q2 2026.
Moisand Fitzgerald Tamayo left its United Therapeutics share count unchanged in Q2 2026.
United Therapeutics made up ﹤0.01% of Moisand Fitzgerald Tamayo's portfolio in Q2 2026, its #438 holding.
Moisand Fitzgerald Tamayo first reported a position in United Therapeutics in Q4 2022 and has held it in 15 quarters since.
Moisand Fitzgerald Tamayo's United Therapeutics position peaked at $5.34K in Q1 2026.
875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Moisand Fitzgerald Tamayo's 13F filing for Q2 2026, filed 13 Jul 2026.